Product
EEC
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
Phase 2 Clinical Trial of Randomized, Blinded, Positive-controlled to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.Status: Recruiting, Estimated PCD: 2024-05-30